60 DEGREES PHARMACEUTICALS, INC. — Form D
60 DEGREES PHARMACEUTICALS, INC. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-24. $1.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-05-24
- Form: D
- Accession: 0001946563-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $1.8M
- Investors: 10
- Date of first sale: 2022-05-19
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-482569
Issuer
- Name: 60 DEGREES PHARMACEUTICALS, INC.
- CIK: 0001946563
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, 20036
- Phone: 202-327-5422
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Geoffrey S Dow | Director | Washington, DC |
| Geoffrey S Dow | Executive Officer | Washington, DC |
Other filings by this issuer (2)
More